Dupixent vs Pomalyst
Side-by-side drug price comparison from Medicare Part D data
Verdict
Dupixent costs 84% less per claim than Pomalyst ($2819.00 vs $17250.00). Neither drug has a generic alternative available. Total Medicare spending: Dupixent at $4.4B vs Pomalyst at $3.3B.
| Metric | Dupixent | Pomalyst |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $2,819* | $17,250 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $4.4B | $3.3B |
| Total Claims | 1,560,000 | 192,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 35.2% | 4.7%* |
| Generic Available | No | No |
| Condition | Autoimmune Diseases | Cancer |
| Total Beneficiaries | 245,000 | 18,000 |
Dupixent costs 84% less per claim than Pomalyst ($2819.00 vs $17250.00). Neither drug has a generic alternative available. Total Medicare spending: Dupixent at $4.4B vs Pomalyst at $3.3B.